share_log

亨迪药业(301211.SZ):主要从事化学原料药(含中间体)及制剂产品的研发、生产和销售

Hengdian Pharmaceutical Industry (stock code 301211.SZ) mainly engages in the research and development, production, and sales of chemical active pharmaceutical ingredients (including intermediates) and formulated products.

Gelonghui Finance ·  Aug 5 03:30

Hengdian Pharmaceutical (301211.SZ) announced on August 5 that the company is mainly engaged in the research and development, production and sales of chemical raw materials (including intermediates) and formulated products, and can provide contract research and development and production services (CDMO) according to customer needs. Contract research and development and production services (CDMO) include intermediates, key starting materials and active pharmaceutical ingredients, meeting customers' different needs from pre-clinical to commercialization stages such as process research and development, pilot testing, commercial production, method validation and registration declaration.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment